Shaping Sustainable Practices in Community Oncology
Key Takeaways from the McKesson “2025 Advancing Community Oncology Report” (as presented in the text)
Here’s a breakdown of the key findings and themes from the provided text, attributed to Ben Jones of McKesson:
1. Personalized Medicine is Expected to Transform Cancer Care:
* High Expectations: 95% of respondents believe personalized medicine will substantially improve patient survival.
* Future Therapies: Over 70% anticipate innovative therapies like CAR T-cell and gene therapies replacing conventional methods within the next 10 years.
* Barriers to Adoption: Systemic barriers are hindering the implementation of these advancements, highlighting the need for collaboration.
2. Expanding Clinical Trial access is Crucial:
* Positive Impact Recognized: Both community physicians (93%) and administrators/staff (93%) acknowledge the positive impact of clinical trials on patient outcomes.
* Access Disparity: Access to clinical trials is perceived as easier in academic settings (85% of physicians, 78% of administrators/staff).
3. Shifting Patient Demographics & Increased Demand for Education:
* Younger Diagnoses: 76% of oncologists report diagnosing cancer in younger patients more frequently.
* Long-Term Care Needs: More patients require long-term cancer care.
* Rising patient Volumes: 62% of oncologists report increased patient volumes.
* Demand for Education: Both physicians (64%) and administrators/staff (77%) see a need for better patient education.
4. AI integration & the Importance of the “Human Touch”:
* AI Concerns: There’s concern about the rapid integration of AI into healthcare systems (EMRs, prior authorizations).
* Lack of Readiness: Very few (2% of physicians, 6% of administrators/staff) feel “entirely ready” for future changes.
* Human Connection Remains Vital: The report emphasizes that emerging technologies should support, not replace, the human element in community oncology.
5. Overall Conclusion:
* Interconnected & Complex Landscape: Oncology is becoming increasingly interconnected and complex.
* Collaboration is Key: Progress depends on effectively linking research, data, and delivery to ensure innovation reaches all patients who can benefit.
Source: 2025 Advancing Community Oncology Report. McKesson. (https://www.mckesson.com/biopharma/advancing-community-oncology-report/)